tegafur has been researched along with Cancer of Ovary in 59 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effects of N-(6-aminohexyl)-1-naphthalenesulfonamide (W-5) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur, FT) and a mixture of FT and uracil (UFT) were determined in nude mice bearing human ovarian carcinoma (KF cells)." | 7.67 | Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas. ( Iwano, I; Kikuchi, Y; Kita, T; Kizawa, I; Kuki, E; Miyauchi, M; Oomori, K, 1989) |
| "Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 5.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
| " 5-Fluorouracil (5-FU) was effective against only one bladder cancer xenograft among 6 cancer xenografts tested." | 3.68 | [Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice]. ( Adachi, S; Akaza, H; Ishitsuka, H; Kanazawa, K; Miwa, M; Nitta, K; Sekiguchi, F; Tokita, H, 1991) |
| "Effects of N-(6-aminohexyl)-1-naphthalenesulfonamide (W-5) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur, FT) and a mixture of FT and uracil (UFT) were determined in nude mice bearing human ovarian carcinoma (KF cells)." | 3.67 | Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas. ( Iwano, I; Kikuchi, Y; Kita, T; Kizawa, I; Kuki, E; Miyauchi, M; Oomori, K, 1989) |
| "Complete cases among them consisted of ovarian cancer 53 cases, uterine cervical cancer 86 cases and endometrial cancer 27 cases for a total of 166 cases." | 2.67 | [Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer]. ( Ibuki, Y; Igarashi, M; Ito, T; Kimura, H; Kosuge, T; Nagayama, M; Nogami, Y; Ohwada, N; Tsukagoshi, T; Yazaki, K, 1992) |
| "Twenty nine patients with ovarian cancer of common epitherial origin who had no evidence of disease proved by computed tomography after the initial operation and chemotherapy were studied." | 2.67 | [Evaluation of UFT administration in patients with ovarian cancer who had no evidence of disease after the initial therapy]. ( Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K; Yokosuka, K, 1990) |
| "Two hundred fifty-nine patients with ovarian cancers were treated with the combination of CDDP, aclarubicin and tegafur." | 2.66 | [Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur]. ( Hiroi, M; Maki, M; Nishiya, I; Saito, Y; Sato, A; Shinagawa, S; Suzuki, M; Wada, Y; Yajima, A, 1989) |
| "Ovarian cancer was suspected, and total abdominal hysterectomy, bilateral salpingo-oophorectomy, and omentectomy were performed." | 1.56 | A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy. ( Aida, T; Baba, T; Saito, T; Sasou, S; Shoji, T; Takeshita, R, 2020) |
| "There was no recurrence for more than 2 years after the lung surgery." | 1.46 | [A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period]. ( Ikeda, H; Kakegawa, S; Matsumoto, I; Saito, D; Takata, M; Takemura, H; Tamura, M; Tanaka, Y; Yoshida, S, 2017) |
| "Ovarian metastasis from the gastric cancer was diagnosed, and the response to 3 courses of weekly PTX was stable disease." | 1.42 | [A Case of Long-Term Survival after Surgeries for Gastric Cancer and Metachronous Ovarian Metastasis]. ( Akasaka, H; Hakamada, K; Kubo, N; Muroya, T; Okano, K; Sakuraba, S; Uchida, C; Wajima, N; Yoshida, T, 2015) |
| "Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 1.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
| "Stage IV gastric cancer has poor prognosis, and median survival time (MST) is reported to range from 6 to 13 months." | 1.40 | [A case of Stage IV gastric cancer was successfully treated with multi combination chemotherapy with S-1]. ( Akita, H; Amagasa, H; Ami, K; Ando, M; Arai, K; Fujiya, K; Fukuda, A; Ganno, H; Gokita, K; Imai, K; Kawai, Y; Kodaka, F; Matsunaga, Y; Nagahama, T; Ohshima, N; Okada, Y; Takagi, M; Tei, S; Yamada, Y, 2014) |
| "However, the Krukenberg tumor rapidly increased in size after 4 years and she complained of abdominal distension." | 1.40 | Giant Krukenberg tumor from a perforated gastric cancer that was successfully removed after multidisciplinary therapy: report of a case. ( Harada, T; Isogai, M; Kamei, K; Kaneoka, Y; Maeda, A; Sunagawa, M; Takayama, Y, 2014) |
| "A 35-year-old female with scirrhous stomach cancer (stage IV) was treated with a combination of 5-aminolevulinic acid (ALA), sodium dichloroacetate (DCA), hyperthermotherapy, and immunotherapy as terminal care." | 1.39 | A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). ( Goto, S; Kamigaki, T; Saito, M; Yano, K, 2013) |
| "In ovary metastasis of gastric cancer, even if accompanied by peritoneum metastasis, ovarian resection as a reduction surgery followed by chemotherapy may improve survival." | 1.36 | [A case of gastric cancer with bilateral ovarian metastasis after gastrectomy performed ovarian resection]. ( Fukunaga, M; Furukawa, H; Imamura, H; Kawabata, R; Kishimoto, T; Miwa, H; Miyanishi, K; Ohzato, H; Yamamoto, T, 2010) |
| "Advanced ovarian cancer is a chemosensitive tumor and most patients initially respond to platinum-based combination chemotherapy with response rates of about 70%, including a high proportion of complete responses." | 1.35 | Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report. ( Aslan, Y; Buyukberber, S; Camci, C; Kalender, ME; Sevinc, A, 2009) |
| "We report here a case of synchronous dermoid cyst with secondary malignant tumor and uterine endometrial adenocarcinoma that responded to UFT." | 1.33 | [A case of synchronous double cancer responding to UFT--dermoid cyst with secondary malignant transformation and uterine endometrial adenocarcinoma]. ( Fukai, H; Maruyama, A; Matsumoto, H; Sakamoto, H; Takami, M; Takimoto, T; Togo, Y; Yamamoto, T, 2005) |
| "Chemotherapies for recurrent gastric cancer have not yet been established." | 1.33 | [A case of advanced gastric cancer with lymphangitis carcinomatosa after operation of Krukenberg tumor treated by TS-1 plus CPT-11 as third-line chemotherapy]. ( Akiba, Y; Hibi, T; Higuchi, H; Iizuka, H; Izumiya, M; Nagata, H; Takaishi, H; Yamagishi, Y, 2005) |
| "Survival of patients with advanced gastric cancer with Krukenberg's tumor is poor." | 1.32 | [A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum]. ( Akiba, Y; Aoki, D; Hibi, T; Ishii, H; Kato, S; Mukai, M; Naito, K; Takada, Y; Watanabe, C, 2003) |
| "A patient with recurrent gastric cancer which infiltrated the pelvic muscle after the treatment of paraaortic lymph node and ovarian metastases was successfully managed by a novel oral anticancer drug, TS-1." | 1.31 | [A case of recurrent gastric cancer successfully treated with TS-1]. ( Higaki, K; Ikeda, T; Kobayashi, N; Ninomiya, M; Ohno, S; Okamura, S; Onoda, T; Shiozaki, S; Takakura, N, 2001) |
| "In cases of advanced ovarian cancer, intermittent CDDP therapy (ICDDPT) was applied after the first operation and induction chemotherapy, and its efficacy and limit were studied." | 1.28 | [Significance of intermittent CDDP therapy for improving long-term prognosis in patients with advanced ovarian cancer]. ( Kawabata, M; Matsumoto, Y; Nakano, M; Sugawa, T; Tsuda, K; Umesaki, N; Yamamoto, A, 1991) |
| "Patients with ovarian cancer had significantly (p less than 0." | 1.27 | Serum selenium in patients with ovarian cancer during and after therapy. ( Kauppila, A; Sundström, H; Yrjänheikki, E, 1984) |
| "Since the incidence of ovarian cancer is increasing, the development of appropriate methods for early diagnosis and treatment of this carcinoma is eagerly awaited." | 1.27 | [Therapeutic results of malignant ovarian tumor]. ( Fukazawa, I; Fukuda, K; Hayashi, K; Masubuchi, K; Masubuchi, S; Miyata, R; Okajima, H; Yokosuka, K, 1984) |
| "A case of an amylase-producing ovarian cancer in 69-year-old woman has been investigated by light and electron microscopy, as well as by amylase isozyme analysis." | 1.27 | [Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report]. ( Chiba, T; Hiura, M; Kaneko, H; Kawamurra, S; Moriwaki, S; Tanaka, M; Yokoyama, T, 1988) |
| "Among the 95 cases of ovarian cancer treated by us between May, 1975 and August, 1978, only 33 were suitable for complete resection." | 1.26 | Combination chemotherapy in advanced ovarian cancer. ( Hanyu, T; Higashiiwai, H; Igarashi, N; Kinii, H; Mori, T; Moritsuka, T; Nagasawa, K; Nakano, M; Sato, A; Sato, S; Suzuki, K; Suzuki, M; Watanabe, M; Yajima, A, 1980) |
| " The group of long term administration of FT-207 and CQ included many patients with good response." | 1.26 | [Combined administration of futraful and esquinone for the treatment of advanced ovarian cancer]. ( Fukuda, O; Inoue, S; Maeyama, M; Nakayama, M; Tajima, C; Tokunaga, T, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (42.37) | 18.7374 |
| 1990's | 7 (11.86) | 18.2507 |
| 2000's | 11 (18.64) | 29.6817 |
| 2010's | 14 (23.73) | 24.3611 |
| 2020's | 2 (3.39) | 2.80 |
| Authors | Studies |
|---|---|
| Shoji, T | 1 |
| Takeshita, R | 1 |
| Saito, T | 1 |
| Aida, T | 1 |
| Sasou, S | 1 |
| Baba, T | 1 |
| Naruse, T | 1 |
| Hirono, Y | 1 |
| Kurebayashi, H | 1 |
| Katayama, H | 1 |
| Sawai, K | 1 |
| Morikawa, M | 1 |
| Koneri, K | 1 |
| Tamaki, M | 1 |
| Murakami, M | 1 |
| Goi, T | 1 |
| Yamada, M | 2 |
| Nakai, K | 1 |
| Inoue, K | 1 |
| Hijikawa, T | 1 |
| Hachimine, T | 1 |
| Yasuda, K | 1 |
| Uemura, Y | 1 |
| Yoshioka, K | 1 |
| Kon, M | 1 |
| Saito, M | 1 |
| Yano, K | 2 |
| Kamigaki, T | 1 |
| Goto, S | 1 |
| Kitayama, J | 1 |
| Ishigami, H | 1 |
| Yamaguchi, H | 1 |
| Yamashita, H | 2 |
| Emoto, S | 1 |
| Kaisaki, S | 1 |
| Watanabe, T | 1 |
| Matsuoka, T | 1 |
| Hosaka, S | 1 |
| Inada, K | 1 |
| Kawamoto, S | 1 |
| Yang, X | 1 |
| Xiang, X | 1 |
| Xia, M | 1 |
| Su, J | 1 |
| Wu, Y | 1 |
| Shen, L | 1 |
| Xu, Y | 1 |
| Sun, L | 1 |
| Ami, K | 1 |
| Gokita, K | 1 |
| Kawai, Y | 1 |
| Matsunaga, Y | 1 |
| Fujiya, K | 1 |
| Ohshima, N | 1 |
| Amagasa, H | 1 |
| Ganno, H | 1 |
| Imai, K | 1 |
| Fukuda, A | 1 |
| Nagahama, T | 1 |
| Ando, M | 1 |
| Okada, Y | 1 |
| Akita, H | 1 |
| Tei, S | 1 |
| Yamada, Y | 1 |
| Takagi, M | 1 |
| Kodaka, F | 1 |
| Arai, K | 1 |
| Yoshida, T | 1 |
| Wajima, N | 1 |
| Akasaka, H | 1 |
| Sakuraba, S | 1 |
| Muroya, T | 1 |
| Kubo, N | 1 |
| Okano, K | 1 |
| Uchida, C | 1 |
| Hakamada, K | 1 |
| Takata, M | 1 |
| Matsumoto, I | 1 |
| Tanaka, Y | 1 |
| Saito, D | 1 |
| Yoshida, S | 1 |
| Kakegawa, S | 1 |
| Tamura, M | 1 |
| Takemura, H | 1 |
| Ikeda, H | 1 |
| Shindo, Y | 1 |
| Tenma, K | 1 |
| Okuyama, M | 1 |
| Hibino, M | 1 |
| Sasaki, Y | 1 |
| Kitamura, T | 1 |
| Nakamura, M | 2 |
| Sasaki, H | 1 |
| Idani, F | 1 |
| Asami, S | 1 |
| Komoto, S | 1 |
| Kubota, T | 1 |
| Kumano, K | 1 |
| Kurose, Y | 1 |
| Kubo, S | 1 |
| Nojima, H | 1 |
| Yoshioka, T | 1 |
| Muro, M | 1 |
| Kin, H | 1 |
| Takakura, N | 2 |
| Imamura, H | 1 |
| Kishimoto, T | 1 |
| Kawabata, R | 1 |
| Furukawa, H | 1 |
| Fukunaga, M | 1 |
| Ohzato, H | 1 |
| Miyanishi, K | 1 |
| Yamamoto, T | 2 |
| Miwa, H | 1 |
| Ebisui, C | 1 |
| Ohkubo, K | 1 |
| Akitake, H | 1 |
| Ohtsuka, M | 1 |
| Maekawa, T | 2 |
| Yoshioka, S | 2 |
| Hama, N | 2 |
| Kashiwazaki, M | 2 |
| Taniguchi, M | 2 |
| Tsujie, M | 2 |
| Konishi, M | 2 |
| Fujimoto, T | 2 |
| Okubo, K | 1 |
| Asukai, K | 1 |
| Hata, T | 1 |
| Nakanishi, M | 1 |
| Suganuma, Y | 1 |
| Nagashima, T | 1 |
| Fujimura, M | 1 |
| Kou, K | 1 |
| Shibuya, M | 1 |
| Sunagawa, M | 1 |
| Isogai, M | 1 |
| Harada, T | 1 |
| Kaneoka, Y | 1 |
| Kamei, K | 1 |
| Maeda, A | 1 |
| Takayama, Y | 1 |
| Shimizu, Y | 3 |
| Akiba, Y | 2 |
| Watanabe, C | 1 |
| Takada, Y | 1 |
| Naito, K | 1 |
| Aoki, D | 1 |
| Mukai, M | 1 |
| Kato, S | 1 |
| Hibi, T | 2 |
| Ishii, H | 1 |
| Katase, K | 1 |
| Kobayashi, Y | 1 |
| Hasumi, K | 2 |
| Takami, M | 1 |
| Maruyama, A | 1 |
| Fukai, H | 1 |
| Matsumoto, H | 1 |
| Togo, Y | 1 |
| Takimoto, T | 1 |
| Sakamoto, H | 1 |
| Yamagishi, Y | 1 |
| Izumiya, M | 1 |
| Higuchi, H | 1 |
| Iizuka, H | 1 |
| Takaishi, H | 1 |
| Nagata, H | 1 |
| Kodama, T | 1 |
| Ishida, H | 1 |
| Okino, T | 1 |
| Okamoto, R | 1 |
| Takahashi, H | 1 |
| Hayashi, N | 1 |
| Mori, K | 1 |
| Noguchi, M | 1 |
| Toshimitsu, H | 1 |
| Matoba, K | 1 |
| Ozasa, H | 1 |
| Shimizu, R | 1 |
| Inagaki, D | 1 |
| Katayama, K | 1 |
| Shiraishi, R | 1 |
| Tanabe, H | 1 |
| Tani, K | 1 |
| Oosawa, H | 1 |
| Wada, H | 1 |
| Yasuda, S | 1 |
| Camci, C | 1 |
| Sevinc, A | 1 |
| Aslan, Y | 1 |
| Kalender, ME | 1 |
| Buyukberber, S | 1 |
| Sugimori, H | 2 |
| Kidera, Y | 1 |
| Matsuyama, T | 2 |
| Yamagata, S | 1 |
| Unno, T | 1 |
| Yamamoto, K | 2 |
| Sugawa, T | 3 |
| Akiyama, J | 2 |
| Sagara, Y | 2 |
| Takeda, Y | 2 |
| Sundström, H | 1 |
| Yrjänheikki, E | 1 |
| Kauppila, A | 1 |
| Fukazawa, I | 1 |
| Masubuchi, S | 1 |
| Okajima, H | 1 |
| Fukuda, K | 1 |
| Hayashi, K | 1 |
| Yokosuka, K | 2 |
| Miyata, R | 1 |
| Masubuchi, K | 1 |
| Grigorova, TM | 1 |
| Vartanian, LG | 1 |
| Marenich, AF | 1 |
| Yajima, A | 3 |
| Higashiiwai, H | 1 |
| Sato, A | 2 |
| Watanabe, M | 1 |
| Mori, T | 2 |
| Suzuki, M | 3 |
| Hanyu, T | 1 |
| Suzuki, K | 1 |
| Kinii, H | 1 |
| Moritsuka, T | 1 |
| Igarashi, N | 1 |
| Nakano, M | 2 |
| Nagasawa, K | 1 |
| Sato, S | 2 |
| Sommer, H | 1 |
| Meinhold, P | 1 |
| Tanaka, M | 2 |
| Jimi, S | 1 |
| Watanabe, E | 1 |
| Kato, Y | 1 |
| Morita, T | 1 |
| Shigyo, R | 1 |
| Nishimura, A | 1 |
| Kawakami, M | 1 |
| Toyota, Y | 1 |
| Tsukamoto, N | 1 |
| Taki, I | 1 |
| Wakisaka, T | 1 |
| Sakahira, H | 1 |
| Yamauchi, R | 1 |
| Inoue, S | 2 |
| Fukuda, O | 1 |
| Tajima, C | 1 |
| Tokunaga, T | 1 |
| Nakayama, M | 1 |
| Maeyama, M | 1 |
| Mäenpää, JU | 1 |
| Heinonen, E | 1 |
| Hinkka, SM | 1 |
| Karnani, P | 1 |
| Klemi, PJ | 1 |
| Korpijaakko, TA | 1 |
| Kuoppala, TA | 1 |
| Laine, AM | 1 |
| Lähde, MA | 1 |
| Nuoranne, EK | 1 |
| Tanaka, K | 1 |
| Kodama, S | 1 |
| Takahashi, T | 1 |
| Honma, S | 1 |
| Maruhashi, T | 1 |
| Tokunaga, A | 1 |
| Takeuchi, Y | 1 |
| Sudou, N | 1 |
| Adachi, S | 3 |
| Onoda, T | 1 |
| Okamura, S | 1 |
| Shiozaki, S | 1 |
| Ohno, S | 1 |
| Higaki, K | 1 |
| Ninomiya, M | 1 |
| Ikeda, T | 1 |
| Kobayashi, N | 1 |
| Ohwada, N | 1 |
| Nagayama, M | 1 |
| Kosuge, T | 1 |
| Tsukagoshi, T | 1 |
| Ibuki, Y | 1 |
| Igarashi, M | 1 |
| Yazaki, K | 1 |
| Ito, T | 1 |
| Nogami, Y | 1 |
| Kimura, H | 1 |
| Ueda, G | 1 |
| Abe, Y | 1 |
| Yoshida, M | 1 |
| Fujiwara, T | 1 |
| Umesaki, N | 2 |
| Yamamoto, A | 1 |
| Matsumoto, Y | 1 |
| Tsuda, K | 1 |
| Kawabata, M | 1 |
| Miwa, M | 1 |
| Sekiguchi, F | 1 |
| Akaza, H | 1 |
| Tokita, H | 1 |
| Nitta, K | 1 |
| Kanazawa, K | 2 |
| Ishitsuka, H | 1 |
| Chen, JT | 1 |
| Nakayama, K | 1 |
| Teshima, H | 1 |
| Hirai, Y | 1 |
| Hamada, T | 1 |
| Fujimoto, I | 1 |
| Yamauchi, K | 1 |
| Ihara, T | 1 |
| Hisamatsu, K | 1 |
| Okamoto, E | 1 |
| Suemitsu, H | 1 |
| Matsuda, M | 1 |
| Nanba, K | 1 |
| Kirimoto, K | 1 |
| Kawamurra, S | 1 |
| Hiura, M | 1 |
| Kaneko, H | 1 |
| Yokoyama, T | 1 |
| Chiba, T | 1 |
| Moriwaki, S | 1 |
| Kou, B | 1 |
| Ooshika, Y | 1 |
| Wada, Y | 1 |
| Shinagawa, S | 1 |
| Saito, Y | 1 |
| Nishiya, I | 1 |
| Maki, M | 1 |
| Hiroi, M | 1 |
| Kikuchi, Y | 2 |
| Oomori, K | 2 |
| Iwano, I | 2 |
| Kizawa, I | 2 |
| Miyauchi, M | 2 |
| Kita, T | 2 |
| Kuki, E | 1 |
| Nagai, S | 2 |
| Kamiya, H | 2 |
| Sato, K | 1 |
| Sakai, K | 2 |
| Yoshiya, N | 1 |
| Misawa, Y | 1 |
| Ishida, M | 1 |
| Yuzawa, H | 1 |
| Takeuchi, S | 1 |
| Kato, K | 1 |
| Sawada, T | 1 |
| Tsukasaki, K | 1 |
| Shibata, S | 1 |
| Okumura, A | 1 |
| Tanaka, T | 1 |
| Onitsuka, Y | 1 |
| Yoshimura, T | 1 |
| Aiko, A | 1 |
| Ikuta, Y | 1 |
| Fukuma, K | 1 |
| Matsuura, K | 1 |
| Mäenpää, J | 2 |
| Kangas, L | 2 |
| Grönroos, M | 2 |
| Söderström, KO | 1 |
| Cantell, K | 1 |
| Franz, G | 1 |
| Lietz, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Docetaxel, Oxaliplatin, Fluorouracil (FLOT Regimen) Combined With Teriprizumab (PD-1) in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis: an Open, One-arm, Exploratory Study[NCT04886193] | 20 participants (Anticipated) | Interventional | 2021-04-16 | Recruiting | |||
| The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer[NCT03007446] | Phase 2 | 20 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tegafur and Cancer of Ovary
| Article | Year |
|---|---|
[Phase III study of gynecologic cancer in Japan].
Topics: Adjuvants, Immunologic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Combina | 2002 |
6 trials available for tegafur and Cancer of Ovary
| Article | Year |
|---|---|
The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
Topics: Aged; Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carbopl | 1995 |
[Clinical results of UFT against ovarian carcinoma].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Female; | 1994 |
[Maintenance chemotherapy using UFT and FT for gynecological malignant tumors. The Gunma Prefectural Society for Study of Chemotherapy for Gynecological Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; | 1992 |
[Evaluation of UFT administration in patients with ovarian cancer who had no evidence of disease after the initial therapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 1990 |
[Combination chemotherapy of ovarian cancer with cisplatinum, aclarubicin and tegafur].
Topics: Aclarubicin; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 1989 |
[Results of the Hamburg ovarian blastoma study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; | 1985 |
52 other studies available for tegafur and Cancer of Ovary
| Article | Year |
|---|---|
A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapy.
Topics: Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Carcinoma, Signet Ring Cell; Drug Combin | 2020 |
[A Long Term Survival Case of Gastric Cancer with Peritoneal Dissemination Responding to Intraperitoneal Chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Human | 2020 |
[A Case Report of Long-Term Survival after SOX Chemotherapy for Metastatic Ovarian Tumor of Gastric Cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Hysterectomy; Kru | 2017 |
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).
Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocol | 2013 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
[A case of delayed subcutaneous metastases of gastric carcinoma effectively treated with S-1 plus cisplatin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combina | 2013 |
Inhibition of JNK3 promotes apoptosis induced by BH3 mimetic S1 in chemoresistant human ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Biomimetic Materials | 2015 |
[A case of Stage IV gastric cancer was successfully treated with multi combination chemotherapy with S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2014 |
[A Case of Long-Term Survival after Surgeries for Gastric Cancer and Metachronous Ovarian Metastasis].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug C | 2015 |
[A Recurrent Case of Thymic Adenocarcinoma Effectively Treated with S-1 Over a Long-Term Period].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Middle Aged; Ova | 2017 |
[A case of simultaneous bilateral metastatic ovarian tumor of colon cancer followed by FOLFOX4 Regimen and oral tegafur/uracil+oral leucovorin after R0 operation].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colectomy; C | 2009 |
[A long-term survival case of bilateral ovarian metastasis of progressive gastric cancer treated by chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplas | 2010 |
[A case of gastric cancer with bilateral ovarian metastasis after gastrectomy performed ovarian resection].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2010 |
[A case of ovarian metastasis from colon cancer successfully treated with multidisciplinary therapy].
Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2010 |
[A case report of primary adenocarcinoma of small intestine].
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
[A case of advanced mullerian cancer successfully treated with S-1 chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Combinations; Female; Humans; O | 2011 |
Giant Krukenberg tumor from a perforated gastric cancer that was successfully removed after multidisciplinary therapy: report of a case.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Mod | 2014 |
[A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; | 2003 |
[Chemotherapy with combination of UFT and cisplatin against metastatic ovarian tumor originating from gastric cancer].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring | 2004 |
[A case of synchronous double cancer responding to UFT--dermoid cyst with secondary malignant transformation and uterine endometrial adenocarcinoma].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Adenosquamous; Combined Modality Therapy; D | 2005 |
[A case of advanced gastric cancer with lymphangitis carcinomatosa after operation of Krukenberg tumor treated by TS-1 plus CPT-11 as third-line chemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2005 |
[A case report of complete response by TS-1 and paclitaxel combination chemotherapy for advanced gastric cancer].
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Drug Administ | 2006 |
[A resected case of effective treatment with TS-1 and CDDP for advanced gastric cancer with carcinomatous ascites].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cholecystectomy; Cisplatin; Combined | 2006 |
[Multiple hepatic metastases and ovarian metastases of colon cancer responding to combined therapy with S-1 and CPT-11--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinations; | 2008 |
Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Combined Modality Therapy; Cys | 2009 |
[Combined chemotherapy of ovarian cancer with special reference to carboquone].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Azirines; Carbazilquinone; Cystadenocarcinoma | 1982 |
[Long-term maintenance chemotherapy for pseudomyxoma peritonei of ovarian origin].
Topics: Aged; Cyclophosphamide; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Neoplasm Seeding; O | 1984 |
[Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Tra | 1984 |
Serum selenium in patients with ovarian cancer during and after therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; | 1984 |
[Therapeutic results of malignant ovarian tumor].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Castration; Combined Modality Therapy; | 1984 |
[Clinical effects of oral administration of UFT on gynecological malignant tumors].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Proto | 1984 |
[Surgical method and combination chemotherapy in treating stage-III and IV ovarian cancer].
Topics: Altretamine; Antineoplastic Agents; Carcinoma; Cyclophosphamide; Drug Therapy, Combination; Evaluati | 1980 |
Combination chemotherapy in advanced ovarian cancer.
Topics: Antineoplastic Agents; Carbazilquinone; Cytarabine; Drug Therapy, Combination; Female; Humans; Ovari | 1980 |
[The problem of accidental paravenous application of cytostatics--case history (author's transl)].
Topics: Antineoplastic Agents; Cyclophosphamide; Cystadenoma; Doxorubicin; Female; Humans; Infusions, Parent | 1981 |
[Long-term chemotherapy with FT-207 for ovarian cancer (author's transl)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Fluorourac | 1981 |
FQC combination chemotherapy for primary malignant ovarian tumor.
Topics: Azirines; Carbazilquinone; Cytarabine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Ovar | 1982 |
[Combined administration of futraful and esquinone for the treatment of advanced ovarian cancer].
Topics: Adenocarcinoma; Azirines; Carbazilquinone; Drug Therapy, Combination; Female; Fluorouracil; Humans; | 1982 |
[A case of recurrent gastric cancer successfully treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Huma | 2001 |
Embryonal carcinoma of the ovary: a six-year survival.
Topics: Adolescent; alpha-Fetoproteins; Carbazilquinone; Chorionic Gonadotropin; Combined Modality Therapy; | 1990 |
[Significance of intermittent CDDP therapy for improving long-term prognosis in patients with advanced ovarian cancer].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality | 1991 |
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; | 1991 |
[Transformation of ovarian yolk sac tumor to immature teratoma following chemotherapy].
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; | 1985 |
[Amylase-producing ovarian cancer treated with postoperative QF chemotherapy--a case report].
Topics: Amylases; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Female; Humans; Middle | 1988 |
[Clinical evaluation of intermittent administration of CDDP in advanced ovarian cancer].
Topics: Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Ovarian Neoplasm | 1989 |
Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas.
Topics: Animals; Calmodulin; Carcinoma; Drug Combinations; Drug Synergism; Female; Fluorouracil; Mice; Mice, | 1989 |
[In vitro effects of 5-FU on gynecologic malignant tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Line; Cells, Cultured; Colony-Fo | 1986 |
[Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Mi | 1988 |
[Effect of calmodulin antagonists (W-5 and W-7) on antitumor activity of Tegafur and UFT (Tegafur plus uracil)].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calmodulin; Drug Synergism; Female; Mice; M | 1988 |
[Preoperative treatment with UFT for patients with ovarian malignant tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Middle Ag | 1985 |
[UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrium; Female; Genital Neoplasms, Female; Huma | 1985 |
Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
Topics: Aclarubicin; Adolescent; Adult; Aged; Altretamine; Animals; Antibiotics, Antineoplastic; Antineoplas | 1985 |
Ultrastructural effects of alpha and gamma interferons and cytostatics on ovarian cancer cells in the subrenal capsule assay (SRCA).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colony-Forming Units Assay; Cycl | 1985 |